COMMUNIQUÉS West-GlobeNewswire

Enovis to Host First Quarter 2026 Results Conference Call on May 7th
10/04/2026
Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
10/04/2026
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing Symposium MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
10/04/2026
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+ brands within the [...]
NeurAxis, Inc. Announces Preferred Stock Dividend
10/04/2026
CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating [...]
Clariane annonce le succès de son offre de 500 millions d’euros d’obligations senior
10/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening®
10/04/2026
DENVER, April 10, 2026 (GLOBE NEWSWIRE) -- Unyte Health, a leader in listening therapy interventions, is proud to announce that Vital Links and Vital Sounds have officially joined its growing family of clinical [...]
Clariane announces the success of its offering of €500 million of senior notes
10/04/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane [...]
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
10/04/2026
Preclinical models demonstrate potential to restore thymic function lost with aging reducing susceptibility to cancer, autoimmune diseases, infections, and reduced vaccine efficacy HOUSTON, April 10, 2026 (GLOBE [...]
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
10/04/2026
Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc [...]
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
10/04/2026
Financing secures path to first NDA submission for buntanetap 6-Month symptomatic data readout anticipated Q1 2027 Alzheimer’s disease Phase 3 trial 75% enrolled Parkinson's disease open-label study 28% enrolled MALVERN [...]
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
10/04/2026
Oral presentations feature phentolamine ophthalmic solution 0.75% RESEARCH TRIANGLE PARK, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage [...]
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
10/04/2026
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- [...]
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
10/04/2026
Allschwil, Switzerland – April 10, 2026 Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to approve the [...]
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
10/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2026 – 7 AM CEST Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Fagron NV invites its shareholders and holders of [...]
Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026
10/04/2026
ORION CORPORATION PRESS RELEASE 10 APRIL 2026 at 9.00 EEST Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026 Orion will publish Interim Report for January–March 2026 on Thursday [...]
Zhen-Ao Group Showcases Core 5'-Nucleotide Breakthroughs in Cambridge, Illuminating a Chinese Path for Global Technology-Driven Anti-Aging
10/04/2026
Cambridge, UK, April 10, 2026 (GLOBE NEWSWIRE) -- On April 8th local time in the UK, the international academic conference Frontiers in Aging, Longevity and Regeneration was held at the University of Cambridge. Jointly [...]
TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC
10/04/2026
Manhattan Mental Health Counseling becomes an in-network TRICARE provider for New York, accepting TRICARE Select and Reserve Select for virtual therapy at Fort Hamilton, Fort Drum, West Point, Camp Smith, and statewide [...]
FDA Accepts NDA for TLX101-Px (Pixclara®)
10/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug Administration (FDA) [...]
Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update
10/04/2026
A 2026 informational release covering what the Leanzene BHB + apple cider vinegar gummy label discloses, where published ingredient research supports category-level claims at studied dosages, how proprietary blend [...]

Pages